In this article, we will take a look at the 13 Best Diversified Dividend Stocks to Buy Right Now. 

Diversified stocks refer to companies that operate across multiple sectors, industries, or regions. These are often large conglomerates, such as Warren Buffett’s Berkshire Hathaway, that generate income from different lines of business. The idea behind diversification is simple. It spreads investments across various areas to reduce risk, limiting the impact if one stock or sector performs poorly.

That said, diversification does not guarantee that investments will move independently of each other. For instance, holding 100 tech stocks may seem safer than owning just one. In reality, those stocks are still likely to move in the same direction. Real diversification comes from going beyond a single sector.

When done well, diversification can reduce volatility while still allowing for returns. Shon Anderson, a Dayton, OH-based CFP and chief wealth strategist at Anderson Financial Strategies, told CNBC Select that it helps balance risk and opportunity. Greg DePalma, a Denver-based CFP and director of advisory services at Empower, compares it to running a fruit stand. DePalma made the following comment:

“If a hurricane wipes out the orange groves in Florida, it would be helpful if you also sold apples from the Northeast or bananas from Hawaii.”

The same idea applies to investing. A well-managed portfolio considers how different assets interact, allowing one to offset the other. Given this, we will take a look at some of the best diversified dividend stocks to invest in.

Our Methodology:

For this list, we selected conglomerate firms that specialize in several different businesses and pay regular dividends to shareholders. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

13. Emerson Electric Co. (NYSE:EMR)

Number of Hedge Fund Holders: 42

On March 27, BMO Capital analyst Daniel DiCicco initiated coverage of Emerson Electric Co. (NYSE:EMR) with a Market Perform rating. It also set a $150 price target on the stock. The firm said Emerson has repositioned itself as a global automation and industrial software company. At the same time, BMO noted it does not see meaningful upside potential to estimates in 2026.

During the fiscal Q1 2026 earnings call, Surendralal Karsanbhai, President, CEO, and Director, marked his fifth year in the role and pointed to the company’s continued shift toward becoming what he described as the world’s leading automation company. He said the business is now aligned with long-term structural trends that, in his view, are expected to support strong growth well into the future. He also laid out the company’s plan for returning value to shareholders. He said Emerson intends to distribute $10 billion, or about 70% of its cumulative cash, through $6 billion in share buybacks and $4 billion in dividends.

Karsanbhai said demand trends remained solid, with underlying orders up 9%. He noted that customers are committing more capital to longer-cycle projects across key growth areas. Activity picked up across North America, India, and the Middle East and Africa. At the segment level, he said Test & Measurement posted an 11% year-over-year increase, while the Ovation business grew 20%, supported by steady demand tied to the power sector.

Emerson Electric Co. (NYSE:EMR) operates as a global technology and software company, providing solutions across a broad set of end markets. The company is organized into seven segments under two main business groups, including Intelligent Devices and Software and Control.

12. The Clorox Company (NYSE:CLX)

Number of Hedge Fund Holders: 48

On March 30, Deutsche Bank lowered its price recommendation on The Clorox Company (NYSE:CLX) to $101 from $112. It reiterated a Hold rating on the shares. The firm pointed to “legitimate and widespread pressures building” across much of the consumer packaged goods industry, tied to the conflict in the Middle East. The analyst noted that stocks in the space underperformed in March. Cost inflation remained a concern, and there were also signs of potential demand destruction from trade-down, along with unfavorable currency movements, according to the research note.

During the fiscal Q2 2026 earnings call, CEO Linda Rendle said the company still expects category growth to come in the 0% to 1% range in the second half of the year. She also said Clorox is working toward stronger market share performance, supported by its planned initiatives.

Rendle highlighted innovation as a key focus for the rest of the fiscal year. She explained that much of the effort will go into launching new products across the company’s major brands. She added that most shelf resets, along with the more noticeable impact from these innovations, are expected to occur later in Q3 or early Q4.

The Clorox Company (NYSE:CLX) operates as a multinational manufacturer and marketer of consumer and professional products. It is organized into four segments: Health and Wellness, Household, Lifestyle, and International.